Member Info for mazik

LSN's proprietary algorithms process CT images of a patient's liver to assess the nodules along the liver surface. This low cost, low-risk, non-invasive procedure provides physicians with new information that may aid in the staging of CLD and has the potential to become the standard of care for a significant global market.

Trytry noproblem, got us all excited but potential of Global sales could take it to multibagger as Mcap of £10M is too low..IMO

trytry, I wish got only 87k shares....

Drax I agree , dont need to ramp

Missed on NCYT and getting this on the bud

10p as Wall Street opens, rerate will continue tomorrow morning 20pplus , it could go up like Nyct

MM have been shaking weak ones on both Nfx and Ctea...GLA On news this will be rerated

BHA-Medical (Pty) Limited, respectively UK and South African entities of the medical equipment supply company, Blackhive Africa Medical ("BHA-Medical"), to deliver an integrated Covid-19 'Test, Monitor, Manage Programme' which has the potential for use and deployment by governments, businesses and organisations.
To date BHA-Medical has supplied approximately 350,000 CE-certified Covid-19 Near-Patient Three-Antibody Tests to businesses within the UK, including to two FTSE 100 companies. BHA will market our product Globally IMO...Multibagger in the making..IMO

Guessed this morning they will shake rattle and roll, and now they will fullfill the demand back to 4p plus at close

100k chunks being bought up, could be news in the pipeline..IMO

This is heading towards 10p , NT to buy had to select "At Best"..caught the demand by surprise...20p

Hasiba "win win" for a change with a multibagger potential...IMO

LSN presents a new way to use CT scans for virtual liver biopsy to help assess individuals with chronic liver disease ("CLD"). CLD is a serious condition that progresses through various stages including liver inflammation, early fibrosis, advanced fibrosis, and cirrhosis. In total, over 2 billion people worldwide have some form of CLD which requires frequent monitoring for proper staging and treatment. Currently, the best way to monitor liver deterioration due to CLD is by undergoing a liver biopsy. The problem with liver biopsies is that they can be quite painful to the patient and expensive. A single liver biopsy can cost between $2,000 and $3,000 per test and is associated with a risk of bleeding. Biopsy sampling is also prone to errors which may result in misdiagnosis.

Market Cap 9 million and very few shares on float potential is multi bagger on FDA approval for global opportunity.

Giggard,
Investors have been warned, hold tight for the potential in front of us :-)

With market cap under £9 million and very few shares we have eenormous potential IMO "Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, announces that it has signed a 50/50 Joint Venture agreement ("JV") through Onside Now Limited, the joint venture entity, with BHA-Medical Limited and BHA-Medical (Pty) Limited, respectively UK and South African entities of the medical equipment supply company, Blackhive Africa Medical ("BHA-Medical"), to deliver an integrated Covid-19 'Test, Monitor, Manage Programme' which has the potential for use and deployment by governments, businesses and organisations.
To date BHA-Medical has supplied approximately 350,000 CE-certified Covid-19 Near-Patient Three-Antibody Tests to businesses within the UK, including to two FTSE 100 companies.

share12345,
you are right, stumbled here on day of the results and realised that it was very cheap at just under £10 million when it should be more like three times its current Market Cap...hence bought 25k shares ....MBO or Predator hold tight for multiples IMO

This should not be less than £30 million market cap, othwise open to predators IMO, Bring it on 30p per share :-)

Iceman888,
Well hoping a double bubble for Xmas, feel two major announcement, Val301 and Val201 final update of Phase 2 on success feel this will be £2 per share IMO, if a collaboration is announced then it depends on fine details..Bring it on..GLA

Looking good for Xmas, with major update within 6 weeks...adding for rerate. market cap £16 million with only 62 million shares...this is start of upward momentum IMO